Audience Quality to Ensure Meaningful TPD Connections
Recently Confirmed to Attend
Teams Attending
Senior Decision-Makers Joining Daily
- Astellas Pharma
- Nurix Therapeutics
- Novartis
- Amgen
- AstraZeneca
- Parabilis Medicines
- Cytokinetics
- Plexium
- Johnson & Johnson
- Eli Lilly
- General Proximity
- Genosco
- Merck & Co
- Astellas X12
- Cytokinetics X5
- Daiichi Sankyo X3
- Eli Lilly X3
- Kymera Therapeutics X5
- Parabilis Medicines X4
- Pfizer X4
- Promega X3
- Sibylla Biotech X4
- Quarry Thera X3
- Merck X4
- TRIANA Biomedicines X2
- XtalPi X3
- Chief Executive Officer
- Vice President, R&D Engineering
- Vice President, Oncology Research
- Vice President, Chemistry
- Senior Director, Lead Discovery
- Senior Director, TPD Engineering
- Director, Modality Technologies
- Director of Biology
Gather alongside the people moving the field forward at every level. Exchange ideas with company founders, strategic decision-makers and investment leaders, while hearing directly from the scientists developing novel technologies, generating critical datasets and pushing the boundaries of induced proximity research. Drawing a global audience, the 9th TPD & Induced Proximity Summit creates a unique environment for cross-disciplinary learning and discussion.
1 Week Only: Get an Exclusive Audience Preview in the Brochure (Ends Friday)
Attending Companies Include
Explore the Agenda
Explore tracks spanning Research Breakthroughs, Discovery, Preclinical Development, Translational and Clinical Development, Latest Tools & Technology and the Future of Induced Proximity.
Partner With Us
Position yourself alongside as the leading solution provider to ensure your brand is at the heart of TPD biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.